Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study.
作者:
主题词
腺癌(Adenocarcinoma);老年人(Aged);抗肿瘤药(Antineoplastic Agents);结直肠肿瘤(Colorectal Neoplasms);女(雌)性(Female);谷氨酸盐类(Glutamates);鸟嘌呤(Guanine);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);姑息疗法(Palliative Care);存活率分析(Survival Analysis);胸苷酸合酶(Thymidylate Synthase)
DOI
10.1023/a:1008372529239
PMID
10586333
发布时间
2020-02-03
- 浏览20

Annals of oncology
1175-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文